Articles |
From the Institute for Biomedical Engineering, University of California, San Diego, La Jolla.
Correspondence to Dr G.W. Schmid-Schönbein, Institute for Biomedical Engineering, University of California, San Diego, La Jolla, CA 92093-0412.
| Abstract |
|---|
|
|
|---|
Key Words: salt hypertension adhesion nitro blue tetrazolium reduction alkaline phosphatase
| Introduction |
|---|
|
|
|---|
To explore the potential role of leukocytes in hypertension, it is necessary that basic aspects of their behavior in the circulation be documented, but few data exist in this respect for any form of hypertension. The Okamoto spontaneously hypertensive rats have approximately twice the number of circulating leukocytes compared with control rats and continue to have skewed differential counts throughout their early and adult lifetime compared with normotensive Wistar-Kyoto rats. There is also evidence for a greater activation of circulating leukocytes in spontaneously hypertensive rats (SHR), as is manifested by elevated levels of oxygen free radical formation,17 but it is uncertain whether these leukocyte abnormalities are specific for the hypertensive state in the SHR or merely a feature characteristic of the SHR strain.
Accordingly, we present here the results of our study of leukocyte properties in the circulation of another hypertensive model, the Dahl salt-dependent hypertensive rat.18 Leukocyte counts, activation, and adhesion in vitro and neutrophil adhesion glycoprotein (CD-18) expression and degranulation are documented for Dahl salt-sensitive (Dahl-S) compared with salt-resistant (Dahl-R) rats.
| Materials and Methods |
|---|
|
|
|---|
13 to 15 weeks old; their body
weights are listed in Table 1
|
Blood Samples
Blood samples (1 mL with heparin as anticoagulant, 10 U/mL) were
taken from the femoral artery catheter after an initial stabilization
period of
30 to 45 minutes. Samples were drawn before general
anesthesia and euthanasia to circumvent the loss of circulating
leukocytes associated with the administration of the anesthetic
agents.17 Unless stated otherwise, all tests on the blood
cells were carried out without delay (within
2 to 3 minutes) to
avoid spontaneous activation of the leukocytes under in vitro
conditions.
Cell Counts
The following measurements were carried out: hematocrit, total
and differential leukocyte counts (with hemocytometer [Fisher
Scientific] and methyl bluestained blood smear, respectively), and
nitro blue tetrazolium (NBT) reduction by granulocytes, as a measure
for spontaneous superoxide formation, according to a modified method of
Park et al19 and Barroso-Aranda and
Schmid-Schönbein.20 NBT reduction can be inhibited
by superoxide dismutase.21
Neutrophil Alkaline Phosphatase and Myeloperoxidase Activity
Measurement of alkaline phosphatase activity in rat neutrophils,
a membrane-associated enzyme, is based on a dye reduction reaction
(procedure No. 86-R, Sigma diagnostics) under standardized conditions.
Briefly, a smear of fresh whole blood was air-dried at room temperature
(20°C) for at least 1 hour under a light cover, fixed in citrate for
30 seconds, and rinsed for 45 seconds with distilled water. The
alkaline phosphatase dye mixture was gently poured onto the wet slide
and kept in the dark for 15 minutes (covered with an aluminum foil).
The slides were rinsed again with distilled water and dried at room
temperature. No counterstain was applied. The dye that accumulated in
the cytoplasm of individual neutrophils was recorded by television
microscopy with a x40 objective, a standardized substage optical
setting, and constant light intensity. Average light absorption by
individual granulocytes was determined with a video photometric window
technique (model 410, Instrumentation for Physiology and Medicine, Inc)
from the transmitted (IE) and incident (II)
average light intensity over the surface of a video window with and
without single neutrophils, respectively. From this measurement, the
absorption, A, due to the alkaline phosphatasemediated neutrophil
staining was computed as follows:
![]() |
1.3% when measured
repeatedly on a single cell. The microscope substage condenser was
positioned as close as possible to the cell to minimize light
diffraction and optimize light absorption by the red alkaline
phosphatase reaction products. One hundred neutrophils were measured on
each glass slide. The histochemical procedures and cell preparation
were standardized, and reproducibility was tested by repeated light
absorption measurements on different slides from the same rat.
Reproducibility was found to be within 2% of the average light
absorption among 10 repeated measurements on the same cell. The level of myeloperoxidase activity in individual granulocytes after reaction with p-phenylenediamine, catechol, and H2O2 (according to procedure No. 390, Sigma diagnostics) was measured with the same optical technique as described above. This procedure requires counterstaining of the cells for optimal recognition and classification. Therefore, we measured the light absorption of neutrophils from the two strains after staining with the counterstain but without myeloperoxidase staining. These average values were identical, indicating that the counterstain had no detectable influence on the comparison between the four groups.
Plasma Phosphatase Activity
The plasma alkaline phosphatase activities were measured
quantitatively (in Sigma units per milliliter) with a colorimetric
determination (procedure No. 104, Sigma diagnostics; reissued February
1989) at 420 nm. Plasma was obtained after a 15-minute centrifugation
of fresh blood samples at 1200g at 6°C in polyethylene
sterile tubes.
Leukocyte Adhesion In Vitro
Cell adherence to nylon fibers in whole blood was determined
within 1 hour after phlebotomy according to a modified fiber filtration
method. Aliquots (0.8 mL) of heparinized whole blood at 37°C were
placed with a pipette onto nylon fiber columns (Leukopak, Travenol
Laboratories) and allowed to pass by gravity. The columns contained
40-mg nylon fibers packed into 1-mL tuberculin syringes from the 0- to
0.22-mL mark (13-mm length). Percent leukocyte adherence was computed
as follows: [1-(PMN count after filtration/PMN count before
filtration) x100, where PMN indicates polymorphonuclear leukocyte.
Neutrophil Membrane Adhesion Glycoprotein Expression
The expression of ß2 integrin on the neutrophil
membrane was determined with a fluorescence-activated cell sorter
(FACS) facility using a monoclonal antibody against rat CD-18 (WT.3,
Serotec) and a secondary antibody (goat anti-mouse IgG, Jackson
ImmunoResearch Laboratories Inc) conjugated with fluorescein
isothiocyanate.22 Heparinized whole blood (50 µL) was
incubated with 50 µL CD-18 (1 mg/mL) and 50 µL secondary antibody
at room temperature in the dark for 15 minutes. The erythrocytes were
lysed by adding 2.0 mL of FACS lysing solution (Becton Dickinson) for
10 minutes in the dark at room temperature. The cells were centrifuged
at 300g for 5 minutes and washed in 1 mL of
phosphate-buffered saline containing 0.1% azide and centrifuged again
at 200g for 5 minutes. Thereafter, the supernatant was
removed, and the cells were gently fixed in 0.5% formaldehyde and
analyzed with a tabletop flow cytometer (FACScan). Neutrophils were
determined from the forward-side scatter diagrams. The percent
CD-18positive cells (with fluorescence intensity above background
without primary antibody, WT.3) and their cell counts were determined,
and the mean intensity of at least 5000 neutrophils was computed from
the fluorescence intensity histograms.
Statistics
The blood samples were processed in pairs of Dahl-R and Dahl-S
rats by the same investigator. The majority of blood samples were
analyzed as blinds to avoid bias in the measurements. Comparisons
between the two animal strains based on mean values (Student's
t test) were carried out by using a MINITAB
statistical software program. Probabilities of P<.05 were
considered statistically significant.
| Results |
|---|
|
|
|---|
Circulating Cell Counts
After salt treatment, the average hematocrit in the Dahl-R rats
remained unchanged, whereas in the Dahl-S rats it was decreased by
28% (Fig 1
). Before salt treatment, the Dahl-S rats
already had a small but significant elevation of circulating leukocyte
count (Fig 1
, P=.034). The number of circulating leukocytes
in salt-treated Dahl-S rats is on average
38% higher than in the
untreated Dahl-S rats (Fig 1
). A comparable trend was also seen in the
Dahl-R rats, but it did not reach a significant value
(P=.226).
|
The number of neutrophils and monocytes in Dahl-S rats was on average
more than twice as high in the salt-treated compared with the untreated
rats. In contrast, the salt diet had no statistically significant
effect on the neutrophil and monocyte counts in the Dahl-R strain. No
significant differences in lymphocyte counts could be detected,
although there was a tendency in salt-treated rats toward higher values
(Fig 2
).
|
Activation in Form of NBT Reduction
The percentage of circulating NBT-positive neutrophils and
monocytes was similar in the two strains on a normal diet, although
there was a significant increase in the number of neutrophils in the
Dahl-S rats that were activated after the salt diet (Figs 3
and 4
, top
panels). Because of the shift in both the
leukocyte and differential counts, the average number of spontaneously
NBT-positive neutrophils or monocytes (in cells per cubic millimeter)
in fresh unseparated blood was higher in Dahl-S rats after the salt
treatment (Figs 3
and 4
, bottom panels). Consequently, the Dahl-S
strain after salt supplement had on average about a 400% increase in
NBT-positive neutrophils and about a 350% increase in NBT-positive
monocytes in the circulation. In contrast, no comparable trend toward
higher activation was found after the salt diet in the Dahl-R strain.
Visual inspection of the typical size of NBT crystals in the leukocytes
suggested no noticeable difference among the four groups.
|
|
Spontaneous Neutrophil Degranulation
In preparations stained for alkaline phosphatase, the light
absorption in neutrophils is on average significantly lower in the
Dahl-S strain (Fig 5
, top panel) after salt treatment,
whereas in the paired blood samples the plasma alkaline phosphatase
levels were significantly higher (Fig 5
, bottom panel). There were no
significant shifts in the Dahl-R strain after the salt supplement. This
observation suggests that circulating neutrophils tend to undergo
spontaneous degranulation after salt treatment in the Dahl-S but not
the Dahl-R strain.
|
If one assumes a linear relation between enzyme activity, stain
intensity, and light absorption, we can estimate from the single-cell
absorption data the anticipated increase of plasma enzyme activity in
the salt-treated Dahl-S strain. The reduction of the average neutrophil
alkaline phosphatase activity in salt-treated Dahl-S rats is equivalent
to 32% of the average value in control Dahl-S rats (Fig 5
), which in
light of the 112% higher neutrophil count in the salt-treated Dahl-S
rats (Fig 3
) amounts to an average loss of enzyme activity per unit
volume of blood in the salt-treated Dahl-S rats equal to 71% of the
activity in control Dahl-S rats. This value is similar to the actual
measured increase of average plasma alkaline phosphatase activity in
the salt-treated Dahl-S rats of 81% compared with the activity in
untreated Dahl-S rats (Fig 5
).
The trend for degranulation after salt supplementation was also
observed in fresh neutrophils stained for myeloperoxidase in secondary
granules of Dahl-S rats but not Dahl-R rats (Fig 6
). The
reduction of myeloperoxidase activity in the circulating neutrophils
amounts on average to
18% in the Dahl-S rat after salt exposure.
|
Leukocyte Adhesion
There were no significant differences in the level of
adhesion to the packed nylon fibers between Dahl rats with or without
the salt diet in either strain of hypertensive rats (Fig 7
).
This form of adhesion can be almost completely blocked with WT 3
antibody against CD-18 membrane integrin (data not shown). The
percentage of circulating neutrophils expressing CD-18 tended to be
elevated on average in both strains after salt supplementation, but the
Dahl-S strain had significantly higher values (Fig 8
, top).
Since the Dahl-S strain after salt addition has significantly higher
neutrophil counts (Fig 3
, bottom), the absolute number of
CD-18positive neutrophils is significantly elevated in the Dahl-S rat
after salt supplementation (Fig 8
, middle panel). The average level of
CD-18 expression on the neutrophil membrane is, however, low in the
hypertensive Dahl-S rat (Fig 8
, bottom panel), in line with the lack of
a shift in adhesion under in vitro conditions (Fig 7
).
|
|
| Discussion |
|---|
|
|
|---|
The Dahl hypertensive model exhibits a range of central vascular and
microvascular abnormalities associated with an elevated peripheral
resistance and a notable elevation of the arteriolar
tone.24 25 There is less evidence of structural
modification of the microvascular network in Dahl hypertensive
rats26 compared with SHR, which exhibit distinctive
structural modifications in the microvascular
network.27 28 Such animals develop a range of vascular
complications,1 including cataracts29 and
higher mortality,30 the severity of which depends on the
amount of salt in the diet, not unlike control rats.31 32
We observed in the present study that the Dahl-S strain also
develops a severe enlargement of the spleen (Table 2
),
which was not encountered in the Dahl-R cohort. This may indicate an
abnormal turnover of circulating cells, as reflected by the reduction
of the hematocrit in the Dahl-S strain on salt supplementation.
|
It is instructive to compare leukocyte properties in the Dahl hypertensive rats with those recorded in SHR. Although there are no differences in the hematocrit between the two control strains (ie, Dahl-R and Wistar-Kyoto rats), the Dahl-R strain exhibits an elevated circulating leukocyte count. The observations on leukocytes in the salt-treated Dahl-S strain closely mirror those recorded in the spontaneously hypertensive strain. Both hypertensive strains have elevated numbers of neutrophils, NBT-positive neutrophils, monocytes, and NBT-positive monocytes, and both exhibit spontaneous neutrophil degranulation.17 33
The present results present a conceptual framework for a better understanding of the vascular and organ complications in salt-dependent hypertensive rats stemming from the abnormal leukocyte kinetics in the circulation. High circulating leukocyte levels, especially in the case of the neutrophils and monocytes, represent a potential risk factor for a number of cardiovascular complications, including myocardial infarction and stroke.34 35 High circulating leukocyte counts will contribute to an increase in microvascular hemodynamic resistance,36 37 38 39 especially since the cells may exhibit pseudopod projections. Their interaction with the endothelium may have a direct influence on the modulation of the tone of the arterioles40 and may modify the production of humoral factors that influence vasoconstriction and blood pressure elevation.41 42 43 Recent evidence suggests that leukocytes contribute significantly to stroke,6 12 14 44 45 46 47 48 one of the main complications in hypertension. Monocytes and neutrophils also play a key role in atherosclerosis49 and in microvascular lesion formation.13
The increased tendency for circulating neutrophils to undergo
spontaneous degranulation can have considerable pathophysiological
consequences, since the degranulation phenomenon is associated with the
release of other proteolytic enzymes contained in
neutrophils.50 When such enzymes are disseminated by way
of the free bloodstream, their site of action is broadened and is no
longer limited to an intracellular phagocytic vacuole, as in the case
of ingestion processes. Cathepsin G or elastase, two enzymes of the
neutrophil primary granules, is known to activate prorenin to renin,
which in turn leads eventually to angiotensin II
production.41 Other reactions may be triggered by the
release of proteases after spontaneous degranulation. Since the ß2
integrin (CD-18) is stored in the cell granules,51 the
observed degranulation is consistent with upregulation of the protein
expression among the cell population (Fig 8
, middle panel), whereas the
level of membrane CD-18 expression on individual cells is depressed
either because of either internalization or shedding of the
glycoprotein.
In principle, two possible mechanisms lead to elevated leukocyte
counts: enhancement of the output of the hemopoietic pool or a
diminished removal of leukocytes from the circulation. We could not
find evidence from the blood smears that premature leukocytes may be
present in the circulation of either animal group. However, it
should be noted that 18-hydroxycorticosterone secretion in adrenal
venous blood is about two times higher in Dahl-S rats than in Dahl-R
rats52 because of a mutation in the cDNA sequence of
P450(11b) from the Dahl-R adrenal gland and suppression of its
steroidogenic activity under sodium loading.53 Expression
of steroids under salt supplementation in Dahl-S rats may serve to
downregulate various membrane-related functions in leukocytes and
endothelial cells.54 Thus, circulating leukocytes may be
kept from regular attachment to the endothelium by virtue of a
reduction of the membrane adhesion protein expression (Fig 8
, bottom),
mediated by way of a corticosteroid mechanism, without abrogating
oxygen radical formation or spontaneous degranulation. This may
represent an early form of cytotoxicity that is expressed by
freely suspended circulating cells. There is also recent evidence to
suggest that neutrophils of the SHR strain are deficient in the
membrane adhesion glycoprotein CD-18 complex.55 In the
SHR, there is evidence for downregulation of P-selectin expression on
endothelial cells56 ; P-selectin is an adhesion molecule
required for rolling of leukocytes on the endothelium.57
L-Arginine treatment, designed to enhance the release of an endothelium-derived relaxing factor (EDRF; eg, nitric oxide), can prevent the development of hypertension in Dahl-S rats.58 Such evidence supports the notion that either an inherent endothelium deficit in EDRF release caused by the salt diet or a breakdown by superoxide, possibly in part derived from circulating and nonadhesive activated leukocytes,59 may lead to a deficiency in EDRF production. Since both Dahl-S and SHR exhibit elevated levels of neutrophils and monocytes and their activation, whereas the effect of L-arginine is quite different in the two strains, the abnormal leukocyte findings may develop as a secondary response to the elevation of arterial blood pressure. This observation is in line with the proposal that the elevation in blood pressure per se is not the sole factor that leads to the complications in hypertension but requires the involvement of a cofactor. The leukocytes may be one such cofactor.
Depression of EDRF release in normotensive animals enhances the attachment of leukocytes to the endothelium.60 The suppression of EDRF is accompanied by hydroperoxide formation in endothelial cells, degranulation of mast cells, and early expression of P-selectin, precipitating the attachment of leukocytes to the endothelium.61 Although these results suggest that EDRF plays an important anti-inflammatory role, the observed suppression of EDRF release in the Dahl hypertensive model appears to be accompanied by inhibition of the inflammatory signal in the form of suppression of leukocyteendothelial membrane attachment.
Although it has been known for several years that the leukocyte cytoplasmic Na+ content is elevated62 because of lowered Na+,K+-ATPase activity,63 further information regarding properties of leukocytes in human hypertension is still limited. Enhanced levels of superoxide by circulating neutrophils, together with the loss of immune competent cells, has been reported.64 65 Neutrophils in hypertensive patients exhibit decreased activity of cytosolic and mitochondrial superoxide dismutase and enhanced lipid peroxidation.66 A leukocyte count in the upper quartile of a normotensive population has been identified as a risk factor for developing hypertension. Observations along these lines need to be expanded in light of the current observations involving hypertensive animal models.
| Acknowledgments |
|---|
Received July 28, 1994; accepted October 5, 1994.
| References |
|---|
|
|
|---|
2. Hadjiisky P, Peyri N. Hypertensive arterial disease and atherogenesis, 1: intimal changes in the old, spontaneously hypertensive rat (SHR). Atherosclerosis. 1982;44:181-199. [Medline] [Order article via Infotrieve]
3. Okamoto K, Aoki K, Nosaka S, Fukushima M. Cardiovascular diseases in the spontaneously hypertensive rat. Jpn Circ J. 1964;28:943-952. [Medline] [Order article via Infotrieve]
4. Suzuki T, Motoyama T, Sato R. Periarteritis nodosa in spontaneously hypertensive rats. Acta Pathol Jpn. 1980;30:907-912. [Medline] [Order article via Infotrieve]
5.
Barroso-Aranda J, Schmid-Schönbein GW, Zweifach BW,
Engler RL. Granulocytes and no-reflow phenomenon in irreversible
hemorrhagic shock. Circ Res. 1988;63:437-447.
6.
Del Zoppo GJ, Schmid-Schönbein GW, Mori E, Copeland BR,
Chang C-M. Polymorphonuclear leukocytes occlude capillaries following
middle cerebral artery occlusion and reperfusion. Stroke. 1991;22:1276-1283.
7. Hernandez LA, Grisham MB, Twohig G, Arfors K-E, Harlan JM, Granger GN. Role of neutrophils in ischemia reperfusion-induced microvascular injury. Am J Physiol. 1987;253(Heart Circ Physiol 22):H699-H703.
8.
Hogg JC. Neutrophil kinetics and lung injury. Physiol
Rev. 1987;67:1249-1295.
9. Korthius RJ, Grisham MB, Granger DN. Leukocyte depletion attenuates vascular injury in postischemic skeletal muscle. Am J Physiol. 1988;254(Heart Circ Physiol 23):H823-H827.
10. Mullane KM, Salomon JA, Kraemer K. Leukocyte-derived metabolites of arachidonic acid in ischemia-induced myocardial injury. Fed Proc. 1987;46:2422-2433. [Medline] [Order article via Infotrieve]
11. Romson JL, Jolly SR, Lucchesi BR. Protection of ischemic myocardium by pharmacological manipulation of leukocyte function. Cardiovasc Rev Reports. 1984;5:690-709.
12. Vasthare US, Heinel LA, Rosenwasser RH, Tuma RF. Leukocyte involvement in cerebral ischemia and reperfusion injury. Surg Neurol. 1990;33:261-265. [Medline] [Order article via Infotrieve]
13. Schröder S, Palinski W, Schmid-Schönbein GW. Activated monocytes and granulocytes, capillary non-perfusion and neovascularization in diabetic retinopathy. Am J Pathol. 1991;139:81-100. [Abstract]
14.
Clark WM, Madden KP, Rothlein R, Zivin JA. Reduction of
central nervous system ischemic injury in rabbits using leukocyte
adhesion antibody treatment. Stroke. 1991;22:877-883.
15. McCord JM. Oxygen derived radicals: a link between reperfusion injury and inflammation. Fed Proc. 1987;46:2402-2406. [Medline] [Order article via Infotrieve]
16. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med. 1989;320:365-376. [Medline] [Order article via Infotrieve]
17.
Schmid-Schönbein GW, Seiffge D, DeLano FA, Shen K,
Zweifach BW. Leukocyte counts and activation in spontaneously
hypertensive and normotensive rats. Hypertension. 1991;17:323-330.
18. Dahl LK, Heine M, Tassinari L. Role of genetic factors in susceptibility to experimental hypertension due to chronic excess salt ingestion. Nature. 1962;194:480-482. [Medline] [Order article via Infotrieve]
19. Park BH, Firrig SM, Smithwick EM. Infection and nitroblue tetrazolium reduction by neutrophils. Lancet. 1968;2:532-534. [Medline] [Order article via Infotrieve]
20.
Barroso-Aranda J, Schmid-Schönbein GW. Transformation of
neutrophils as indicator of irreversibility in hemorrhagic shock.
Am J Physiol. 1989;257:H846-H852.
21. Barroso-Aranda J, Chavez-Chavez RH, Mathison JC, Suematsu M, Schmid-Schönbein GW. Circulating neutrophil kinetics during tolerance in hemorrhagic shock using bacterial lipopolysaccharide. Am J Physiol. 1994;166:H415-H421.
22. Peakman M, Tredgar JM, Davies ET, Davenport M, Dunne JB, Williams R, Vergani D. Analysis of peripheral blood mononuclear cells in rodents by three-colour flow cytometry using a small-volume lysed whole blood technique. J Immunol Methods. 1993;158:87-94. [Medline] [Order article via Infotrieve]
23. Folkow B. The resistance vasculature: functional importance in the circulation. In: Bevan JA, Halpern W, Mulvaney MJ, eds. The Resistance Vasculature. Totowa, NJ: Humana Press; 1991:23-43.
24.
Boegehold MA, Kotchen TA. Effect of dietary salt on the
skeletal muscle microvasculature in Dahl rats. Hypertension. 1990;15:420-426.
25. Takeshita A, Mark AL. Neurogenic contribution to hindquarters vasoconstriction during high sodium intake in Dahl strain of genetically hypertensive rat. Circ Res. 1978;43(suppl I):I-86-I-91.
26. Boegehold MA, Kotchen TA. Arteriolar network morphology in gracilis muscle of rats with salt-induced hypertension. Microvasc Res. 1990;40:169-178. [Medline] [Order article via Infotrieve]
27. Engelson ET, Schmid-Schönbein GW, Zweifach BW. The microvasculature in skeletal muscle, II: arteriolar network anatomy in normotensive and spontaneously hypertensive rats. Microvasc Res. 1986;31:356-374. [Medline] [Order article via Infotrieve]
28. Schmid-Schönbein GW, Delano FA, Chu S, Zweifach BW. Wall structure of arteries and arterioles feeding the spinotrapezius muscle of normotensive and spontaneously hypertensive rats. Int J Microcirc Clin Exp. 1990;9:47-66. [Medline] [Order article via Infotrieve]
29.
Rodriguez-Sargent C, Cangiano JL, Berrios Cabàn G,
Marrero E, Martinez-Maldonado M. Cataracts and hypertension in
salt-sensitive rats: a possible ion transport defect.
Hypertension. 1987;9:304-308.
30.
Dahl LK, Knudsen KD, Heine MA, Leitl GJ. Effects of chronic
excess salt ingestion: modification of experimental hypertension in the
rat by variation in the diet. Circ Res. 1968;22:11-18.
31. Koletsky S. Hypertensive vascular disease produced by salt. Lab Invest. 1958;7:377-385. [Medline] [Order article via Infotrieve]
32. Meneely GR, Tucker RG, Darby WJ, Auerbach SH. Chronic sodium chloride toxicity in the albino rat. J Exp Med. 1953;98:71-70. [Abstract]
33. Shen K, Sung K-LP, Tozer JR, DeLano FA, Zweifach BW, Whittemore D, Schmid-Schönbein GW. Biophysical properties, degranulation and priming of leukocytes in spontaneously hypertensive rats. Biochem Cell Biol. In press.
34.
Ernst E, Hammerschmidt E, Bagge U, Matrai A, Dormandy JA.
Leukocytes and the risk of ischemic disease. JAMA. 1987;257:2318-2324.
35. Prentice RL, Szatrowski TP, Kato H, Mason MW. Leukocyte counts and cerebrovascular disease. J Chron Dis. 1982;35:703-714. [Medline] [Order article via Infotrieve]
36. Braide M, Amundson B, Chien S, Bagge U. Quantitative studies on the influence of leukocytes on the vascular resistance in a skeletal muscle preparation. Microvasc Res. 1984;27:331-352. [Medline] [Order article via Infotrieve]
37. Thompson TN, La Celle PL, Cokelet GR. Perturbation of red cell flow in small tubes by white blood cells. Pflügers Arch. 1989;413:372-377.
38.
Sutton DW, Schmid-Schönbein GW. Elevation of organ
resistance due to leukocyte perfusion. Am J Physiol. 1992;262:H1646-H1650.
39. Warnke K, Skalak TC. The effects of leukocytes on blood flow in a model skeletal muscle capillary network. Microvasc Res. 1990;40:118-136. [Medline] [Order article via Infotrieve]
40.
Mehta JL, Lawson DL, Nicolini FA, Ross MH, Player DW. Effects
of activated polymorphonuclear leukocytes on vascular smooth muscle
tone. Am J Physiol. 1991;261:H327-H334.
41.
Dzau VJ, Gonzelez D, Kaempfer C, Dublin C, Wintroub BU. Human
neutrophils release serine proteases capable of activating prorenin.
Circ Res. 1987;60:595-601.
42. Sessa WC, Kaw S, Hecker M, Vane JR. The biosynthesis of endothelin-1 by human polymorphonuclear leukocytes. Biochem Biophys Res Commun. 1991;174:613-618. [Medline] [Order article via Infotrieve]
43. Wintroub BU, Klickstein LB, Dzau VJ, Watt KWK. Granulocyte-angiotensin system: Identification of angiotensinogen as the plasma protein substrate of leukocyte cathepsin. G Biochemistry. 1984;23:227-232.
44.
Dutka AJ, Kochanek PM, Hallenbeck JM. Influence of
granulocytopenia on canine cerebral ischemia induced by air embolism.
Stroke. 1989;20:390-395.
45.
Hallenbeck JM, Dutka AJ, Tanishima T, Kochanek PM, Kumaroo KK,
Thompson CB, Obrenovitch TP, Contreras TJ. Polymorphonuclear leukocyte
accumulation in brain regions with low blood flow during the early
postischemic period. Stroke. 1986;17:246-253.
46.
Hallenbeck JM, Dutka AJ, Kochanek PM, Siren A. Stroke risk
factors prepare rat brainstem tissues for modified local Shwartzman
reaction. Stroke. 1988;18:863-869.
47.
Mercuri M, Ciuffetti G, Robinson M, Toole J. Blood cell
rheology in acute cerebral infarction. Stroke. 1989;20:959-962.
48.
Pozzilli C, Lenzi GL, Argentino C, Carolei A, Rasura M,
Signore A, Bozzao L, Pozzilli P. Imaging of leukocytic infiltration in
human infarcts. Stroke. 1985;16:251-256.
49. Gerrity RG. The role of the monocyte in atherogenesis, I: transition of blood-borne monocytes into foam cells in fatty lesions. Am J Pathol. 1981;103:181-190. [Abstract]
50. Dewald B, Bretz U, Baggiolini M. Exocytosis induced in neutrophils by chemotactic agents and other stimuli. In: Keller H, Till GO, eds. Leukocyte Locomotion and Chemotaxis. Agents and Actions Supplements. Basel, Switzerland: Birkhauser Verlag; 1983:371-381.
51. Miller LJ, Bainton DF, Borregaard N, Springer TA. Stimulated mobilization of monocyte Mac-1 and p150,95 adhesion proteins from an intracellular vesicular compartment to the cell surface. J Clin Invest. 1987;80:535-544.
52.
Rapp JP, Dahl LK. Adrenal steroidogenesis in rats bred for
susceptibility and resistance to the hypertensive effect of salt.
Endocrinology. 1971;88:52-65.
53. Matsukawa N, Nonaka Y, Higaki J, Nagano M, Mikami H, Ogihara T, Okamoto M. Dahl's salt-resistant normotensive rat has mutations in cytochrome P450(11b), but the salt-sensitive hypertensive rat does not. Proc Natl Acad Sci U S A. 1993;268:9117-9121.
54.
Cronstein BN, Kimmel SC, Levin RI, Martiuik F, Weissmann G. A
mechanism for the antiinflammatory effects of corticosteroids: the
glucocorticoid receptor regulates leukocyte adhesion to endothelial
cells and expression of endothelial-leukocyte adhesion molecule 1 and
intercellular adhesion molecule 1. Proc Natl Acad Sci
U S A. 1992;89:9991-9995.
55.
Arndt H, Granger N. Leukocyte-endothelial cell adhesion in
spontaneously hypertensive and normotensive rats.
Hypertension. 1993;21:667-673.
56. Suzuki H, Schmid-Schönbein GW, Suematsu M, DeLano F, Forrest MJ, Miyasaka M, Zweifach BW. Restoration of deficient leukocyte-endothelial cell adhesive interaction in spontaneously hypertensive rats by a glucocorticoid inhibitor. Hypertension. In press.
57. Lawrence MB, Springer TA. Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Cell. 1991;65:859-873. [Medline] [Order article via Infotrieve]
58. Chen PY, Sanders PW. L-Arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats. J Clin Invest. 1991;88:1559-1567.
59. Gryglewski RJ, Palmer RMJ, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature. 1986;320:454-456. [Medline] [Order article via Infotrieve]
60.
Kubes P, Suzuki M, Granger DN. Nitric oxide: An endogenous
modulation of leukocyte adhesion. Proc Natl Acad Sci
U S A. 1991;88:4651-4655.
61.
Suematsu M, Tamatami T, DeLano FA, Miyasaka M, Forrest M,
Suzuki H, Schmid-Schönbein GW. Microvascular oxidative stress
preceding leukocyte activation elicited by in vivo nitric oxide
suppression. Am J Physiol. 1994;266:H2410-H2415.
62. Edmonson RPS, Thomas RD, Hilton PJ, Jones NF. Abnormal leukocyte composition and sodium transport in essential hypertension. Lancet. 1975;1:1003-1005. [Medline] [Order article via Infotrieve]
63. Posten L, Sewell RB, Wilkinson SP, Richardson PJ, Williams R, Clarkson EM, MacGregor GA, De Wardener HE. Evidence for a circulating sodium transport inhibitor in essential hypertension. Br Med J. 1981;282:847-849.
64. Ananchenko VG, Kuznetsov SV, Vakolyuk RM, Vakolyuk VS, Strizhova NV, Malashenkova IK, Kim IS. Neutrophil and lymphocyte activity in essential hypertension. Sovetskaia Meditsina. 1988;7:32-35.
65. Ananchenko VG, Vakolyuk RM, Kuznetsov SV, Malashenkov IK, Streitsova RV, Strizhova NV. The NBT test in hypertensive patients. Sovetskaia Meditsina. 1986;10:3-5.
66. Rahman I, Nath N. Glutathione and its redox system, superoxide anion and superoxide dismutases of polymorphonuclear leukocytes in essential hypertension. Indian J Med Res. 1988;88:64-70.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
Y. Ozawa, H. Kobori, Y. Suzaki, and L. G. Navar Sustained renal interstitial macrophage infiltration following chronic angiotensin II infusions Am J Physiol Renal Physiol, January 1, 2007; 292(1): F330 - F339. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-W. Gu, N. Tian, M. Shparago, W. Tan, A. P. Bailey, and R. D. Manning Jr. Renal NF-{kappa}B activation and TNF-{alpha} upregulation correlate with salt-sensitive hypertension in Dahl salt-sensitive rats Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2006; 291(6): R1817 - R1824. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. DeLano, R. Balete, and G. W. Schmid-Schonbein Control of oxidative stress in microcirculation of spontaneously hypertensive rats Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H805 - H812. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sela, R. Mazor, M. Amsalam, C. Yagil, Y. Yagil, and B. Kristal Primed Polymorphonuclear Leukocytes, Oxidative Stress, and Inflammation Antecede Hypertension in the Sabra Rat Hypertension, November 1, 2004; 44(5): 764 - 769. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Galinanes and A. G Fowler Role of clinical pathologies in myocardial injury following ischaemia and reperfusion Cardiovasc Res, February 15, 2004; 61(3): 512 - 521. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sun, J. Zhang, L. Lu, S. S. Chen, M. T. Quinn, and K. T. Weber Aldosterone-Induced Inflammation in the Rat Heart : Role of Oxidative Stress Am. J. Pathol., November 1, 2002; 161(5): 1773 - 1781. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Caimi, R. L. Presti, C. Carollo, M. Musso, F. Porretto, B. Canino, A. Catania, and G. Cerasola Polymorphonuclear Integrins, Membrane Fluidity, and Cytosolic Ca2+ Content After Activation in Essential Hypertension Hypertension, November 1, 2000; 36(5): 813 - 817. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Kurose, R. Wolf, W. Cerwinka, and D. N. Granger Microvascular Responses to Ischemia/Reperfusion in Normotensive and Hypertensive Rats Hypertension, August 1, 1999; 34(2): 212 - 216. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Dorffel, C. Latsch, B. Stuhlmuller, S. Schreiber, S. Scholze, G. R. Burmester, and J. Scholze Preactivated Peripheral Blood Monocytes in Patients With Essential Hypertension Hypertension, July 1, 1999; 34(1): 113 - 117. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Swei, F. Lacy, F. A. DeLano, and G. W. Schmid-Schonbein Oxidative Stress in the Dahl Hypertensive Rat Hypertension, December 1, 1997; 30(6): 1628 - 1633. [Abstract] [Full Text] |
||||
![]() |
C. L. Thomas, J. E. Artwohl, H. Suzuki, X.-p. Gao, E. White, A. Saroli, R. M. Bunte, and I. Rubinstein Initial Characterization of Hamsters With Spontaneous Hypertension Hypertension, August 1, 1997; 30(2): 301 - 304. [Abstract] [Full Text] |
||||
![]() |
S. Komatsu, J. Panes, J. M. Russell, D. C. Anderson, V. R. Muzykantov, M. Miyasaka, and D. N. Granger Effects of Chronic Arterial Hypertension on Constitutive and Induced Intercellular Adhesion Molecule-1 Expression In Vivo Hypertension, February 1, 1997; 29(2): 683 - 689. [Abstract] [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |